NIT
GHDX

NumerixS Investment Technologies’s Genomic Health, Inc. GHDX Stock Holding History

NumerixS Investment Technologies’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-700
Closed -$41K – 1354
2019
Q2 		$41K Sell
700
-8,900
-93% -$527K 0.01% 811
2019
Q1 		$664K Buy
9,600
+5,800
+153% +$430K 0.09% 282
2018
Q4 		$242K Buy
+3,800
New +$266K 0.08% 286
2017
Q1 		– Sell
-4,000
Closed -$118K – 1465
2016
Q4 		$118K Buy
+4,000
New +$122K 0.01% 821
2016
Q3 		– Sell
-2,500
Closed -$65K – 1389
2016
Q2 		$65K Buy
+2,500
New +$66.4K 0.01% 928

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

NumerixS Investment Technologies's GHDX Position: Q3 2019 in Review

NumerixS Investment Technologies sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 700 shares — an estimated $41K sold.

NumerixS Investment Technologies first reported a position in GHDX in Q2 2016 and held it in 5 quarters. The position peaked at $664K in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • NumerixS Investment Technologies reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 700 Genomic Health, Inc. shares in Q3 2019, an estimated $41K.
  • NumerixS Investment Technologies first reported a position in Genomic Health, Inc. in Q2 2016 and held it in 5 quarters.
  • NumerixS Investment Technologies's Genomic Health, Inc. position peaked at $664K in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on NumerixS Investment Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.